Guangdong, China

Shuwen Xu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuwen Xu: Innovator in Cephalosporin Compounds

Introduction

Shuwen Xu is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Shuwen Xu holds a patent for "Cephalosporin compounds comprising a C3 thio-methyl moiety substituted with N-containing heterocyclic group, and a C7 thiourea acetamido group, their preparations and uses thereof." This patent discloses a cephalosporin compound of formula I, along with its preparation methods and potential uses. The method involves reacting a starting cephalosporin with specific chemical agents to create a compound that can be used in treating infectious diseases.

Career Highlights

Shuwen Xu is associated with Guangzhou Baiyunshan Pharmaceutical Co., Ltd., where he continues to contribute to pharmaceutical research and development. His work is characterized by a focus on innovative solutions to combat infectious diseases, showcasing his commitment to improving healthcare outcomes.

Collaborations

Shuwen Xu collaborates with talented colleagues, including Mao Chen and Shaoxuan Zhu, who contribute to his research efforts. Their teamwork enhances the potential for groundbreaking discoveries in the pharmaceutical field.

Conclusion

Shuwen Xu's contributions to the development of cephalosporin compounds highlight his role as an innovator in the pharmaceutical industry. His patent reflects a significant advancement in the treatment of infectious diseases, underscoring the importance of his work in improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…